These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 20021066)

  • 1. Platelet hyperfunction as risk factor for chronic and acute coronary events.
    Rao GH
    Toxicol Mech Methods; 2005; 15(6):425-31. PubMed ID: 20021066
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Pharmacotherapy of arteriosclerosis and its complications. Effect of ACE inhibitors and HMG-CoA-reductase inhibitors].
    Tschudi MR; Noll G; Lüscher TP
    Schweiz Med Wochenschr; 1997 Apr; 127(15):636-49. PubMed ID: 9198890
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Hypertension and vascular diseases: molecular and cellular mechanisms].
    Lüscher TF
    Schweiz Med Wochenschr; 1995 Feb; 125(7):270-82. PubMed ID: 7878405
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of platelets in the pathophysiology of acute coronary syndrome.
    Massberg S; Schulz C; Gawaz M
    Semin Vasc Med; 2003 May; 3(2):147-62. PubMed ID: 15199478
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Factor XII (Hageman factor) is a missing link between stress and hypercoagulability and plays an important role in the pathophysiology of ischemic stroke.
    Eggers AE
    Med Hypotheses; 2006; 67(5):1065-71. PubMed ID: 16757126
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Non-conventional hemostatic risk factors for coronary heart disease in individuals with spinal cord injury.
    Khan B; Bauman WA; Sinha AK; Kahn NN
    Spinal Cord; 2011 Aug; 49(8):858-66. PubMed ID: 21606930
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Platelets: pleiotropic roles in atherogenesis and atherothrombosis.
    Linden MD; Jackson DE
    Int J Biochem Cell Biol; 2010 Nov; 42(11):1762-6. PubMed ID: 20673808
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Redox signaling in hypertension.
    Paravicini TM; Touyz RM
    Cardiovasc Res; 2006 Jul; 71(2):247-58. PubMed ID: 16765337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pathophysiology and clinical aspects of fibrinolysis and inhibition of coagulation. Experimental and clinical studies with special reference to women on oral contraceptives and selected groups of thrombosis prone patients.
    Jespersen J
    Dan Med Bull; 1988 Feb; 35(1):1-33. PubMed ID: 3277796
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Helicobacter pylori (H. pylori) infection in coronary artery disease: influence of H. pylori eradication on coronary artery lumen after percutaneous transluminal coronary angioplasty. The detection of H. pylori specific DNA in human coronary atherosclerotic plaque.
    Kowalski M
    J Physiol Pharmacol; 2001 Aug; 52(1 Suppl 1):3-31. PubMed ID: 11795863
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased platelet cholesterol and decreased percentage volume of platelets as a secondary risk factor for coronary artery disease.
    Ravindran R; Krishnan LK
    Pathophysiol Haemost Thromb; 2007; 36(1):45-51. PubMed ID: 18332614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mechanisms of cellular synchronization in the vascular wall. Mechanisms of vasomotion.
    Matchkov VV
    Dan Med Bull; 2010 Oct; 57(10):B4191. PubMed ID: 21040688
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endothelium dysfunction in the coronary circulation.
    Lüscher TF; Noll G
    J Cardiovasc Pharmacol; 1994; 24 Suppl 3():S16-26. PubMed ID: 7700060
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mechanisms of platelet activation: need for new strategies to protect against platelet-mediated atherothrombosis.
    Jennings LK
    Thromb Haemost; 2009 Aug; 102(2):248-57. PubMed ID: 19652875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of platelet recruitment by endothelial cell CD39/ecto-ADPase: significance for occlusive vascular diseases.
    Marcus AJ; Broekman MJ; Drosopoulos JH; Pinsky DJ; Islam N; Maliszewsk CR
    Ital Heart J; 2001 Nov; 2(11):824-30. PubMed ID: 11770867
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Thrombocyte-vascular wall interaction and coronary heart disease].
    Lüscher TF
    Schweiz Med Wochenschr; 1991 Dec; 121(51-52):1913-22. PubMed ID: 1763300
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The role of platelets in haemostasis, thrombosis, immune defense and inflammation].
    Jurk K; Kehrel BE
    Dtsch Med Wochenschr; 2008 May; 133(21):1130-5. PubMed ID: 18478507
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Platelets: key players in vascular inflammation.
    Projahn D; Koenen RR
    J Leukoc Biol; 2012 Dec; 92(6):1167-75. PubMed ID: 22923486
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Porcine von Willebrand disease: implications for the pathophysiology of atherosclerosis and thrombosis.
    Fuster V; Griggs TR
    Prog Hemost Thromb; 1986; 8():159-83. PubMed ID: 3550894
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Modulation of hepatic inflammatory risk markers of cardiovascular diseases by PPAR-alpha activators: clinical and experimental evidence.
    Zambon A; Gervois P; Pauletto P; Fruchart JC; Staels B
    Arterioscler Thromb Vasc Biol; 2006 May; 26(5):977-86. PubMed ID: 16424352
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.